Brusamolino E, Gotti M, Fiaccadori V. THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY. Mediterr J Hematol Infect Dis [Internet]. 2012 Apr. 6 [cited 2024 Nov. 21];4(1):e2012022. Available from: https://www.mjhid.org/mjhid/article/view/2012.022